Neurodegeneration in Newborns After Anesthetics

Status Completed

Clinical Trial Summary

The purpose of the study is to quantify biomarkers of neural damage in neonates exposed to varying levels of volatile anesthetic in utero.

Clinical Trial Description

This study will enroll 130 pregnant patients undergoing C-section or fetal surgery with EXIT (Ex Utero Intrapartum Treatment) procedures under epidural or general anesthesia with low (0.75 MAC) or high (2.5 MAC) concentrations of desflurane. Patients will be recruited from both the Hospital of the University of Pennsylvania (100 C Section) and Children's Hospital of Philadelphia (30 EXIT procedure).

The standard of care protocol for patients undergoing anesthesia for these cases will be followed throughout the surgery. These include monitoring and management of blood pressure, heart rate and rhythm, ventilation, oxygenation, temperature, and fluid status. Management of these parameters will be at the discretion of the clinical team. The choice of the anesthetic technique will also be at the discretion of the clinical team. Typical anesthetic management includes the following:

C-section under epidural anesthesia: induction and maintenance with 1.5% lidocaine, sodium bicarbonate and 1:200,000 epinephrine

C-section under general anesthesia: induction with propofol 2 mg/kg and succinylcholine 2 mg/kg intravenously; maintenance with desflurane 4.5-5%

EXIT procedure under general anesthesia: induction with propofol 2 mg/kg and succinylcholine 2 mg/kg intravenously; maintenance with desflurane 15-18%

1. After the baby is delivered, and the umbilicus is cut, two ml of blood will be taken from the umbilical vein and artery on the placenta side. A portion of the blood will be used for the blood gas and the remainder will be used for the S100B study assay.

2. 5 ml of blood will be taken from the mother via the existing intravenous catheter.

3. 5 ml of amniotic fluid will be obtained at hysterotomy and will be used for the S100B study assay.

All subjects will receive standard of care post operative clinical care and monitoring. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03064607
Study type	Observational
Source	University of Pennsylvania
Contact
Status	Completed
Phase
Start date	November 5, 2010
Completion date	February 6, 2018

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04577430` - Effects of Dexmedetomidine on Cardiac Electrophysiology in Patients Under General Anesthesia During Perioperative Period	N/A
Completed	`NCT03708692` - Menstrual Cycle Phases on Recovery and Cognitive Function
Recruiting	`NCT03422315` - Population Pharmacokinetics and Clinical Individual Dosage Regimen of Propofoll Injection	N/A
Completed	`NCT02771067` - The Utility of Pulse Pressure Variation to Predict the Fluid Responsiveness During Pneumoperitoneum and Reverse-Trendelenburg Position	N/A
Completed	`NCT05063461` - Evaluation of the Analgesia Nociception Index With Varying Remifentanil Concentrations Under Sevoflurane	N/A
Completed	`NCT03294226` - Comparison of AuraGain With I-gel for Pediatric Patients	N/A
Not yet recruiting	`NCT03643029` - The Accuracy of the Performance and Placement Test for Predicting Supraglottic Airway Device (SAD) Position in the Hypopharynx as Confirmed With Video Laryngoscopy	N/A
Completed	`NCT01945411` - Assessment of Facial Measurements, the Length of Mouth Corner-mandible Angle and Incisors-mandible Angle, for Determining the Proper Sizes of Oropharyngeal Airway	N/A
Not yet recruiting	`NCT01678066` - A Prospective Study to Bilaterally Compare a Non-Invasive Cardiac Output Monitor	N/A
Completed	`NCT01705743` - Minimum Alveolar Concentration of Sevoflurane With Nitrous Oxide Inducing Isoelectric EEG	Phase 4
Completed	`NCT00972491` - The Optimal Time to Put Laryngeal Mask Airway in the Mouth Under General Anesthesia	N/A
Completed	`NCT00741507` - Unhealthy Alcohol Drinking and Anesthetic Requirement in Women	N/A
Completed	`NCT01096212` - Efficacy and Safety of Sevofran in Patients Scheduled for Elective Surgery Under General Anesthesia	Phase 4
Completed	`NCT00532402` - Continuous and Discontinuous Determination of Propofol Concentration in Breathing Gas	N/A
Completed	`NCT00599066` - Intraoperative M-Entropy Measurements	N/A
Completed	`NCT00468494` - Can Blood Glucose Levels During the Perioperative Period Identify a Population at Risk for Hyperglycemia?	N/A
Recruiting	`NCT00492453` - Spinal Versus General Anesthesia for Laparoscopic Cholecystectomy	N/A
Recruiting	`NCT03745079` - Correlation Between Core Temperature and Skin Temperature Measured by 3M SpotOn
Completed	`NCT04094376` - Comparison of Morning Operation and Evening Operation on Postoperative Sleep Quality and Pain Under General Anesthesia	N/A
Enrolling by invitation	`NCT03672734` - Volume and pH of Gastric Contents in Patients Undergoing Gynecologic Laparoscopic Surgery During Emergence From General Anesthesia

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.